JD Health FY26 H1 profit rises 32.6% to RMB 3.44 billion; revenue climbs 15.9% to RMB 40.89 billion

• JD Health posted IFRS revenue of RMB 40.89 billion, up 15.9% year over year.
• IFRS profit for the period climbed 32.6% to RMB 3.44 billion; basic earnings per share rose to RMB 1.08.
• IFRS operating income jumped 49.2% to RMB 3.17 billion; non-IFRS operating income rose 40.3% to RMB 3.48 billion.
• Pharmacy network grew to more than 450 offline JD Pharmacy stores across 10 cities; medical insurance payment coverage expanded to 40 cities.
• AI push broadened, including “JD Zhiyi” for doctors, an upgraded “Dr. Da Wei” agent with health-record memory, and a Beijing integrated healthcare center launch.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JD Health International Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260813-12282413), on August 13, 2026, and is solely responsible for the information contained therein.